The absence of studies linking transporter function with microbiota-dependent inflammatory and redox pathways highlights a clear gap in the current literature and underscores the need for the present investigation, providing crucial insights into elucidating the molecular basis of Mrp2 dysregulation and identifying potential therapeutic targets in obesity. The gene discussed is ABCC2; the disease is obesity due to melanocortin 4 receptor deficiency.